TMEM170B and renal cell carcinoma: Interestingly, the lower expression of TMEM170B significantly decreased the OS ratio in human uterine (37% vs. 68%, P < 0.05, Supplementary Fig. 5b) and renal cell carcinoma (69% vs. 88%, P < 0.05, Supplementary Fig. 5c).